Used primarily as an intermediate in the synthesis of clarithromycin, a broad-spectrum antibiotic. It plays a key role in modifying the erythromycin structure to enhance acid stability and improve bioavailability. This compound enables the production of semi-synthetic macrolide antibiotics effective against a wide range of bacterial infections, including respiratory, skin, and soft tissue pathogens. Its derivatives are also explored for improved antimicrobial activity and reduced side effects compared to parent erythromycin.